Kathleen Mangotich v. HHS - Tdap, Miller Fisher-Guillain-Barre syndrome (2025)

Kathleen Mangotich filed a petition on June 10, 2021, alleging that Tdap and/or meningococcal vaccines administered on June 16, 2020, caused Miller Fisher-Guillain-Barre syndrome. The public merits resolution is a stipulation and does not describe the full clinical course of her neurologic illness.

Respondent denied that Ms. Mangotich's alleged GBS or residual effects were caused-in-fact by the Tdap or meningococcal vaccines, and denied that the vaccines caused any other injury or current condition.

The case involved substantial attorney work and interim fee proceedings before the final stipulation. Special Master Thomas L.

Gowen adopted the stipulation on May 8, 2025. Ms.

Mangotich received a lump-sum award of $45,000.00 for all Vaccine Act damages. Later fee decisions concerned attorney fees and costs only.

She was represented by Paul A. Green of the Law Office of Paul Green in Pasadena, California.